IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Medicamen Organics IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in New Delhi and caters to Pharmaceutical sector. GYR Capital Advisors Private is the merchant banker of Medicamen Organics IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st February 2024.
Medicamen Organics IPO open date is 21st June 2024 and close date is 25th June 2024. IPO Allotment Date is 26th June 2024 and Listing date is 28th June 2024.Medicamen Organics IPO size is Rs 10.54 Cr. crores with IPO price of Rs 34.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
GYR Capital Advisors Private Limited is the book-running lead manager of the Medicamen Organics IPO. Kfin Technologies Limited is the Registrar and Market Maker is Giriraj Stock Broking Private Limited for Medicamen Organics IPO.
Medicamen Organics IPO anchor investors are the below investors. The number of anchor investors in this IPO is 2.
| Anchor Investor Name | No. of shares Allotted | Offer Price (in Rs.) | Amount Invested (in Rs.) |
|---|---|---|---|
| Rajasthan Global Securities | 444,000.00 | ₹34.00 | ₹15,096,000.00 |
| SB OPPORTUNITIES FUND | 432,000.00 | ₹34.00 | ₹14,688,000.00 |
Medicamen Organics IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Medicamen Organics IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on Manufactures, and distributes pharmaceutical dosages. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Medicamen Organics IPO size is ₹ 10.54 Cr. Crores with fresh issue size of Rs 10.54 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Medicamen Organics IPO is expected to be 26th June 2024, after the finalization of basis of allotment. Investors can check Medicamen Organics IPO allotment status on the registrars website, Kfin Technologies Limited. Medicamen Organics IPO refund dates are 27th June 2024.
Medicamen Organics IPO is expected to be listed on 28th June 2024.
The upper price band for the Medicamen Organics IPO is set at ₹ 34.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Medicamen Organics IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Medicamen Organics IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 25th June 2024. After submission, funds are blocked until the basis of allotment of Medicamen Organics IPO is finalised.
The merchant banker for Medicamen Organics IPO is GYR Capital Advisors Private Limited . GYR Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Medicamen Organics IPO RHP for further details.
The registrar for Medicamen Organics IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Medicamen Organics IPO through their official website or helpline.
Medicamen Organics IPO was subscribed 993.56 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 10.54 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.81 Cr.
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
GYR Capital
SME IPO by BRLM so far:
47
City:
New Delhi
SME IPO so far:
152
Revenue (annualised):
₹ 25.27 cr.
PE
Ratio:
15.41x
Average Sector PE Ratio: 20.29x
Medicamen Organics IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Medicamen Organics Financial Review Page
Merchant Banker(s) of Medicamen Organics IPO: GYR Capital Advisors Private Limited
Medicamen Organics IPO subscription was 993.56 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Medicamen Organics IPO listed at a listing price of 144.70 against the offer price of 34.00.
The current market price of Medicamen Organics is 28.95.
Why Us?
